Your browser doesn't support javascript.
Old drug fluvoxamine, new hope for COVID-19.
Hashimoto, Yaeko; Suzuki, Takuji; Hashimoto, Kenji.
  • Hashimoto Y; Department of Respirology, Chiba University Graduate School of Medicine, Chiba, 260-8670, Japan.
  • Suzuki T; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba, 260-8670, Japan.
  • Hashimoto K; Department of Respirology, Chiba University Graduate School of Medicine, Chiba, 260-8670, Japan.
Eur Arch Psychiatry Clin Neurosci ; 272(1): 161-163, 2022 Feb.
Article in English | MEDLINE | ID: covidwho-1391862
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fluvoxamine / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Eur Arch Psychiatry Clin Neurosci Journal subject: Neurology / Psychiatry Year: 2022 Document Type: Article Affiliation country: S00406-021-01326-z

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fluvoxamine / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Eur Arch Psychiatry Clin Neurosci Journal subject: Neurology / Psychiatry Year: 2022 Document Type: Article Affiliation country: S00406-021-01326-z